Le Vaccin Vers une Nouvelle Stratégie, ex Vaccin Contre la COVID-19 ( Etude Epidémiologique dans la Ville de Sétif )

Abstract

Vaccines have certainly improved the quality of life and they continue to show a good result on global infant mortality rates. However, when the COVID-19 crisis hit the healthcare system, a new vaccine hesitancy that has never been apparent before is suddenly detected. The purpose of this study is to evaluate the efficacy, safety and general knowledge of the anti-COVID-19 vaccines available in Algeria and to assess the role of the pharmacist as a link between the vaccine production laboratories and the general population. Our study is carried out on a sample of 306 volunteers from the population and 40 pharmacists based in the city of Sétif, using two anonymous questionnaires and for a period starting from December 1, 2021 to March 31, 2022. Based on our survey we conducted : more than half of the population is not vaccinated, they presented many reasons but the major one was the lack of confidence in official information, on the other hand the vaccinated subjects are convinced of the need for the vaccine personally. Several disturbances in the responses were noted reflecting the overall uncertainty regarding the lacking health sources. For pharmacists, 94% have not received training on vaccines, which prevents them from answering questions about their effectiveness, contraindications, side effects and storage criteria. 82% of them do not want to cooperate with the State in the act of vaccination justifying their choice mainly by the limited space. Thus, it is necessary, even indispensable, to reorganize our information concerning these vaccines to convey them more clearly and to reassess the position of approved pharmacists in the fight against COVID-19.